Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
[Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.]
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Erratum to: Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.
Outcome of children with acute disseminated encephalomyelitis in a tertiary care center in India.
Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
[The specialised MS networks, at the heart of the organisation of patient paths].
Cuprizone does not induce CNS demyelination in nonhuman primates.
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica.
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
Is MS an inflammatory or primary degenerative disease?
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Pages
« first
‹ previous
…
581
582
583
584
585
586
587
588
589
…
next ›
last »